Agonist of proteinase-activated receptor 2 increases painful behavior produced by alpha, beta-methylene adenosine 5′-triphosphate

NeuroReport

Volumn 17, Issue 12, 2006, Pages 1257-1261

  Zhu, Wan Jun ^a   Dai, Yi ^a   Fukuoka, Tetsuo ^a   Yamanaka, Hiroki ^a   Kobayashi, Kimiko ^a   Obata, Koichi ^a   Wang, Shenglan ^a   Noguchi, Koichi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

ATP; Dorsal root ganglion; Nociception; P2X3; Pain; Proteinase activated receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA BETA METHYLENE ADENOSINE 5' TRIPHOSPHATE; PHOSPHATE BUFFERED SALINE; PROTEIN FOS; PROTEINASE ACTIVATED RECEPTOR 2; PURINE P2X3 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BEHAVIOR, ANIMAL; DRUG SYNERGISM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; OLIGOPEPTIDES; ONCOGENE PROTEINS V-FOS; PAIN; PAIN MEASUREMENT; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PAR-2; RECEPTORS, PURINERGIC P2;

EID: 33748362643     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000230518.31833.5d     Document Type: Article

References (21)

1. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 1998; 274:C1429-C1452.
2. Saifeddine M, al-Ani B, Cheng CH, Wang L, Hollenberg MD. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 1996; 118:521-530.
3. Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 2001; 7:821-826.
4. Vergnolle N, Hollenberg MD, Sharkey KA, Wallace JL. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 1999; 127:1083-1090.
5. Seeliger S, Derian CK, Vergnolle N, Bunnett NW, Nawroth R, Schmelz M, et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. Faseb J 2003; 17:1871-1885.
6. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000; 6:151-158.
7. Hoogerwerf WA, Zou L, Shenoy M, Sun D, Micci MA, Lee-Hellmich H, et al. The proteinase-activated receptor 2 is involved in nociception. J Neurosci 2001; 21:9036-9042.
8. Kawabata A, Kinoshita M, Nishikawa H, Kuroda R, Nishida M, Araki H, et al. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest 2001; 107:1443-1450.
9. Burnstock G. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 2001; 22:182-188.
10. Dunn PM, Zhong Y, Burnstock G. P2X receptors in peripheral neurons. Prog Neurobiol 2001; 65:107-134.
11. Kobayashi K, Fukuoka T, Yamanaka H, Dai Y, Obata K, Tokunaga A, et al. Differential expression patterns of mRNAs for P2X receptor subunits in neurochemically characterized DRG neurons in the rat. J Comp Neurol 2005; 481:377-390.
12. Burnstock G, Wood JN. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 1996; 6:526-532.
13. Paukert M, Osteroth R, Geisler HS, Brandle U, Glowatzki E, Ruppersberg JP, et al. Inflammatory mediators potentiate ATP-gated channels through the P2X(3) subunit. J Biol Chem 2001; 276:21077-21082.
14. Dai Y, Moriyama T, Higashi T, Togashi K, Kobayashi K, Yamanaka H, et al. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004; 24:4293-4299.
15. Hamilton SG, McMahon SB, Lewin GR. Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin. J Physiol 2001; 534:437-445.
16. Dai Y, Fukuoka T, Wang H, Yamanaka H, Obata K, Tokunaga A, et al. Contribution of sensitized P2X receptors in inflamed tissue to the mechanical hypersensitivity revealed by phosphorylated ERK in DRG neurons. Pain 2004; 108:258-266.
17. Dai Y, Iwata K, Kondo E, Morimoto T, Noguchi K. A selective increase in Fos expression in spinal dorsal horn neurons following graded thermal stimulation in rats with experimental mononeuropathy. Pain 2001; 90:287-296.
18. Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM, et al. Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 1999; 376:127-138.
19. Souslova V, Cesare P, Ding Y, Akopian AN, Stanfa L, Suzuki R, et al. Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 2000; 407:1015-1017.
20. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000; 407:1011-1015.
21. Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, et al. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA 2002; 99:17179-17184.